Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Appointed director
|
|
Denali Therapeutics Inc. (DNLI)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/08/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 05/08/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 11/03/2022 |
10-Q
| Quarterly Report for the period ended September 30, 2022 |
| 08/08/2022 |
10-Q
| Quarterly Report for the period ended June 30, 2022 |
| 05/05/2022 |
10-Q
| Quarterly Report for the period ended March 31, 2022 |
| 11/04/2021 |
10-Q
| Quarterly Report for the period ended September 30, 2021 |
| 08/04/2021 |
10-Q
| Quarterly Report for the period ended June 30, 2021 |
| 05/05/2021 |
10-Q
| Quarterly Report for the period ended March 31, 2021 |
| 11/05/2020 |
10-Q
| Quarterly Report for the period ended September 30, 2020 |
| 08/07/2020 |
10-Q
| Quarterly Report for the period ended June 30, 2020 |
| 05/07/2020 |
10-Q
| Quarterly Report for the period ended March 31, 2020 |
| 11/06/2019 |
10-Q
| Quarterly Report for the period ended September 30, 2019 |
| 08/06/2019 |
10-Q
| Quarterly Report for the period ended June 30, 2019 |
| 05/08/2019 |
10-Q
| Quarterly Report for the period ended March 31, 2019 |
| 11/08/2018 |
10-Q
| Quarterly Report for the period ended September 30, 2018 |
| 08/09/2018 |
10-Q
| Quarterly Report for the period ended June 30, 2018 |
| 05/11/2018 |
10-Q
| Quarterly Report for the period ended March 31, 2018 |
|
|